Clinicopathological evaluation of renal allograft treated with anti-CD25 monoclonal antibody

Clinical Transplantation, Supplement

Volumn 19, Issue 14, 2005, Pages 49-53

  Okamoto, Masahiko ^a   Akioka, Kiyokazu ^b   Higuchi, Atsushi ^b   Kadotani, Yayoi ^b   Ushigome, Hidetaka ^b   Uryuhara, Kenji ^a   Kaihara, Satoshi ^b   Yoshimura, Norio ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Anti CD25 monoclonal antibody; Kidney transplantation; Protocol biopsy

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MIZORIBINE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 22244472302     PISSN: 13996738     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00404.x     Document Type: Article

References (6)

1. Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC. Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation 2004: 77: 166.
2. Keown P, Balshaw R, Khorasheh S et al. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation. BioDrugs 2003: 17: 271.
3. Adu D, Cockwell P, Ives NJ, Shaw J, Wheatley K. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ. 2003: 326: 789.
4. Sheashaa HA, Bakr MA, Ismail AM, Sobh MA, Ghoneim MA. Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial. Nephrology 2003: 16: 393.
5. Wiland AM, Fink JC, Weir MR et al. Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial. Transplantation 2004: 77: 422.
6. Praditpornsilpa K, Avihingsanon Y, Kupatawintu P et al. Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody. Transplant Proc 2004: 36(Suppl 2): 487S.